Drug eluting stents (DES) have decreased

Size: px
Start display at page:

Download "Drug eluting stents (DES) have decreased"

Transcription

1 JACC: CARDIOVASCULAR IMAGING VOL. 5, NO. 11, 1 1 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN X/$36. PUBLISHED BY ELSEVIER INC. BRIEF REPORT OCT-Verified Peri-Strut Low-Intensity Areas and the Extent of Neointimal Formation After 3 Years Following Stent Implantation Jin-Ho Choi, MD, PHD,* Juan F. Granada, MD, Jung-Sun Kim, MD, PHD, Young Bin Song, MD, PHD,* Joo-Yong Hahn, MD, PHD,* Seung Hyuk Choi, MD, PHD,* Armando Tellez, MD, Krzysztof Milewski, MD, Myeong-Ki Hong, MD, PHD, Yangsoo Jang, MD, PHD, Sang Hoon Lee, MD, PHD,* Hyeon-Cheol Gwon, MD, PHD* Seoul, Korea; and New York, New York Drug eluting stents (DES) have decreased substantially the neointimal formation after percutaneous coronary intervention (PCI). However, DES are not free from neointimal hyperplasia (NIH) and stent thrombosis, which are related to the delayed arterial healing following DES implantation. The recently introduced optical coherence tomography (OCT) enables a detailed investigation of vessel healing. The presence of peri-strut low intensity (PLI) has been described as a potential marker of abnormal neointimal healing (1,). We investigated the late healing characteristics of stents implanted over 3 years, specifically the potential impact of PLI on NIH and restenosis. OCT imaging (M, Lightlab Imaging, Westford, Massachusetts) was performed in 99 patients who were treated with bare-metal stents (BMS), sirolimus-eluting stents (SES) (Cypher, Cordis, Bridgewater, New Jersey), or paclitaxeleluting stents (PES) (Taxus, Boston Scientific, Natick, Massachusetts) from September 7 to From the *Department of Medicine, Samsung Medical Center, Cardiac and Vascular Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York; and the Division of Cardiology, Severance Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea. Support was provided by Clinical Research Development (CRS18-8-1) of Samsung Medical Center. All authors have reported that they have no relationships relevant to the contents of this paper to disclose. Manuscript received January 6, 1; revised manuscript received February 8, 1, accepted February 9, 1. August 9. The inclusion criteria were stent implanted in de novo lesion and time from index PCI 3 years. The exclusion criteria were left main, stent thrombosis, or target lesion revascularization. Cross-sectional images of the stented segments were analyzed at 1-mm intervals. PLI was defined as homogenous low-intensity area around a stent strut without significant signal attenuation behind the area on a strut basis. The severity of PLI on a cross-sectional basis was evaluated semiquantitatively by PLI score by the extent of PLI occupying the number of quadrants. Neointimal thickness and malapposition of each strut, neointimal lipid pool, calcification, microvessel, and OCT-derived thin cap neoatheroma (OCT- TCNA) were also defined (Fig. 1A) (3). A total of 3,365 OCT cross sections from 15 stents were assessed. After exclusion of overlapping stents (,197 struts [6.7%]) and side branches mm (77 struts [.8%]), a total of 3,3 struts (9%) and 3,53 cross sections were included in the analysis. By the OCT strut-level analysis, PLI was most common in BMS (19.%), followed by PES (1.6%) and SES (6.%; p.1) (Table 1). NIH was higher in struts displaying PLI than struts without PLI in all stents (p.1 for all). Interestingly, the NIH thickness was.3 mm even in the BMS strut without PLI, and it was.5 mm in SES struts with PLI (Fig. 1B). Significant correlation between the severity of PLI and the degree of NIH was found in both the cross-sectional and stent-level analyses (r.537 to.86; p.5) (Fig. 1B, Table 1). The frequency of OCT-TCNA per stent was 7.9% to

2 JACC: CARDIOVASCULAR IMAGING, VOL. 5, NO. 11, 1 NOVEMBER 1: Figure 1. Representative Images of PLI and Impact of PLI on Strut-Level Neointimal Thickness and Stent-Level Angiographic Late Loss (A) Representative optical coherence tomography (OCT) findings of neointima. Peri-strut low intensity (PLI) (white arrows) is seen as homogenous lower intensity adjacent to stent struts. PLI score is defined as the number of quadrants, to, occupied by PLI. PLI may appear granular as shown by image in the rightmost middle row. OCT-derived thin cap neoatheroma (OCT-TCNA) was defined as the presence of TCNA having an angle of signal-poor lipid pool (blue arrowhead) in quadrants and a fibrous cap thickness 65 m (pink arrows) in 3 consecutive images. Microvessels are small vesicular tubular structures (pink arrows) visible in 1 cross-sectional image. Neointimal calcification is a well-delineated signal-poor mass with a sharp border (blue arrowhead). Continued on the next page. 15.6% and not different between stent types (p nonsignificant) (Table 1). The severity of PLI correlated with angiographic late loss in all groups (r.7 to.583; p.5) (Fig. 1B, Table 1). The presence of PLI in one quadrant of OCT image was related to a 6.6- to 13.-fold increase of binary restenosis after adjustment for stent area (p.5) (Table 1). The vascular healing response of BMS implantation is known to be initial regression of neointima followed by a plateau at least up to 3 years, whereas that of DES is a mild but continuous growth. Little is known about the characteristics of late neointima. Our study showed that PLI is a common finding long after stent implantation and appears to be involved in neointimal proliferation.

3 1158 JACC: CARDIOVASCULAR IMAGING, VOL. 5, NO. 11, 1 NOVEMBER 1: B1 Distribution of Neointimal Thickness Over Strut 7 1,.19±.18 mm 3,.1±.15 mm 6.9±.18 mm 8, p<.1.6±.3 mm 6 p<.1.7±.7 mm, 1,5 1, 5 p<.1.56±.31 mm Neointimal Thickness (mm) Neointimal Thickness (mm) Neointimal Thickness (mm) PLI (-) PLI (+) B Mean Neointimal Area (mm ) B3 5 r =.736, p<.1 r =.611, p< r =.83, p< Late Loss (mm) r =.583, p = r =.7, p = r =.6, p = Figure 1. Continued (B1) Distribution of neointimal thickness by PLI in strut level. The neointimal thickness over struts with PLI (light blue bars) was higher than neointimal thickness over struts without PLI (red bars) in all stent types (all p.1). Even the neointimal thickness of sirolimus-eluting stents (SES) with PLI was higher than those of bare-metal stents (BMS) without PLI ( mm vs mm; p.1). Correlation between severity of PLI and degree of neointimal hyperplasia or angiographic late loss is shown in B and B3, respectively. PES paclitaxel-eluting stents. The histopathology of PLI is still not known well. PLI was correlated with the quality of the neointima with different stent types (,,5). In our study, the presence of PLI was the strongest factor related to neointimal proliferation. Considering contribution of continuous inflammation, fibrin deposition, extracellular matrix accumulation, or formation of neoatherosclerosis to

4 JACC: CARDIOVASCULAR IMAGING, VOL. 5, NO. 11, 1 NOVEMBER 1: Table 1. Strut-Level, Cross-Sectional, and Stent-Level OCT Analysis p Value Strut-level analysis N 7,7 7,551 15,11 Neointimal thickness, mm Uncovered strut 1. (9) 9.1 (686) 11. (1,6).1 Malapposed strut (3) 1.7 (13). (35).1 Strut with PLI 19. (1,51) 1.6 (955) 6. (97).1 Cross-sectional level analysis N Stent area, mm Luminal area, mm Neointimal area, mm Neointimal area, % No. of PLI PLI score Lipid pool 8.5 (63).1 (3) 3. (7).1 Microvessel 15.9 (118). (17) 1.9 (3).1 Calcification. (3).7 (5).3 ().1 Correlation between neointimal area and r.6 r.5 r.593.1* no. of PLI Stent-level analysis N Left anterior descending artery lesion 59. (19) 6. (18) 66.7 ().37 Imaged length, mm Imaged length, %* Stent length, mm Volumetric obstruction, % Volumetric obstruction, mm Any PLI within stent 87.5 (8) 8. () 66.7 ().7 Mean PLI score Lipid pool 59.3 (19) 33.3 (1) 15.9 (1).1 OCT-TCNA 15.6 (5) 13.3 () 7.9 (5).9 Correlation between mean neointimal r.736 r.611 r.83.1* area and strut with PLI Angiographic binary restenosis and OCT imaging Mean PLI score per stent 6.61 (7 7.8) 5.93 ( ) 19.9 ( ) Stent area, mm.9 (.559 1).6 (.11 1.).988 (.68 55) Values are mean SD, n (%), or odds ratio (95% confidence interval). The Kruskal-Wallis test was used for comparison among stent types. p Value among 3 stent types, except *Pearson s correlation coefficient (p.5) and odds ratio of multivariate logistic regression analysis (p.5). BMS bare-metal stent(s); OCT optical coherence tomography; OCT-TCNA OCT-derived thin cap neoatheroma; PES paclitaxel-eluting stent(s); PLI peri-strut low intensity; SES sirolimus-eluting stent(s). the late neointimal growth, PLI may be the trace of burnt-out neointimal growth or sustained residual biological process occurring adjacent to the stent. The limitations of this study are its crosssectional nature and lack of neointimal histology. The histological validation and serial examination of our findings deserve further investigation because they may have clinical implications among patients undergoing stent implantation. Reprint requests and correspondence: Dr. Hyeon-Cheol Gwon, Department of Medicine, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, 5 Irwon-dong, Gangnam-gu, Seoul , Korea. hcgwon6@gmail.com.

5 116 JACC: CARDIOVASCULAR IMAGING, VOL. 5, NO. 11, 1 NOVEMBER 1: REFERENCES 1. Teramoto T, Ikeno F, Otake H, et al. Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment. Circ J 1;7: Inoue T, Shite J, Yoon J, et al. Optical coherence evaluation of everolimuseluting stents 8 months after implantation. Heart 11;97: Kim JS, Jang IK, Fan C, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial. J Am Coll Cardiol Intv 9;: Miyoshi N, Shite J, Shinke T, et al. Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure 6- month follow-up. Circ J 1;7: Tanaka N, Terashima M, Rathore S, et al. Different patterns of vascular response between patients with or without diabetes mellitus after drugeluting stent implantation: optical coherence tomographic analysis. J Am Coll Cardiol Intv 1;3:17 9. Key Words: optical coherence tomography y peri-strut low intensity y stent

OCT in the Evaluation of Vascular Healing Following DES Implantation: Will It Be a Helpful Tool to Reduce Stent Thrombosis?

OCT in the Evaluation of Vascular Healing Following DES Implantation: Will It Be a Helpful Tool to Reduce Stent Thrombosis? OCT in the Evaluation of Vascular Healing Following DES Implantation: Will It Be a Helpful Tool to Reduce Stent Thrombosis? Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research

More information

malapposition assessed by OCT

malapposition assessed by OCT Stent t coverage and malapposition assessed by OCT Myeong-Ki Hong, M.D. Ph D Professor of Medicine Division of Cardiology, Severance Cardiovascular Hospital Yonsei University College of Medicine, Seoul,

More information

Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents

Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents J-S Kim, 1 I-K Jang, 2 J-S Kim, 1 T H Kim, 1 M Takano, 3 T Kume, 4 N

More information

Abstract Background: Methods: Results: Conclusions:

Abstract Background: Methods: Results: Conclusions: Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li

More information

Relationship between Angiographic Late Loss and 5-Year Clinical Outcome after Drug-Eluting Stent Implantation

Relationship between Angiographic Late Loss and 5-Year Clinical Outcome after Drug-Eluting Stent Implantation Original Article http://dx.doi.org/10.3349/ymj.2013.54.1.41 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 54(1):41-47, 2013 Relationship between Angiographic Late Loss and 5-Year Clinical Outcome after

More information

Clinical Application of OCT in Stent Evaluation

Clinical Application of OCT in Stent Evaluation Imaging & Physiology Summit 2010 in Soul #1. Basics of Image Interpretation: IVUS/VH/OCT Clinical Application of OCT in Stent Evaluation Mitsuyasu Terashima, MD, PhD, FACC Stent implantation Stent Apposition

More information

as a Mechanism of Stent Failure

as a Mechanism of Stent Failure In-Stent t Neoatherosclerosis e osc e os s as a Mechanism of Stent Failure Soo-Jin Kang MD., PhD. University of Ulsan College of Medicine, Heart Institute Asan Medical Center, Seoul, Korea Disclosure I

More information

Catch-up Phenomenon: Insights from Pathology

Catch-up Phenomenon: Insights from Pathology Catch-up Phenomenon: Insights from Pathology Michael Joner, MD CVPath Institute Inc. Gaithersburg, MD USA Path Lessons learned from the BMS and DES (1 st Gen) era Neointimal Thickness [mm] In Stent Re

More information

Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study

Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study DOI 10.1007/s10554-012-0032-6 ORIGINAL PAPER Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study Tuomas Lehtinen

More information

2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:

2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57: Pathology of In-stent Neoatherosclerosis in BMS and DES 197 BMS, 103 SES, and 106 PES with implant duration >30 days The incidence of neoatherosclerosis was significantly greater in DES (31%) than BMS

More information

Comparison of Optical Coherence Tomographic Assessment between First- and Second-Generation Drug-Eluting Stents

Comparison of Optical Coherence Tomographic Assessment between First- and Second-Generation Drug-Eluting Stents Original Article http://dx.doi.org/10.3349/ymj.2012.53.3.524 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 53(3):524-529, 2012 Comparison of Optical Coherence Tomographic Assessment between First- and

More information

A New Strategy for Discontinuation of Dual Antiplatelet Therapy

A New Strategy for Discontinuation of Dual Antiplatelet Therapy Journal of the American College of Cardiology Vol. 60, No. 15, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.06.043

More information

PCI for Long Coronary Lesion

PCI for Long Coronary Lesion PCI for Long Coronary Lesion Shift of a General Idea with the Introduction of DES In the Bare Metal Stent Era Higher Restenosis Rate With Increasing Stent Length and Decreasing Stent Area Restenosis.6.4.2

More information

Analysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent

Analysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent Analysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent implantation. Department of Cardiology, Ehime Prefectural Imabari

More information

SMJ Singapore Medical Journal

SMJ Singapore Medical Journal SMJ Singapore Medical Journal ONLINE FIRST PUBLICATION Online first papers have undergone full scientific review and copyediting, but have not been typeset or proofread. To cite this article, use the DOIs

More information

HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February Drug-eluting stents Are they all equal?

HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February Drug-eluting stents Are they all equal? HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February 2014 Drug-eluting stents Are they all equal? Vassilis Spanos Interventional Cardiologist, As. Director 3 rd Cardiology Clinic Euroclinic

More information

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus OPTICAL COHERENCE TOMOGRAPHY (OCT) IVUS and OCT IVUS OCT

More information

Incidence and predictors of drug-eluting stent fractures in long coronary disease

Incidence and predictors of drug-eluting stent fractures in long coronary disease International Journal of Cardiology 133 (2009) 354 358 www.elsevier.com/locate/ijcard Incidence and predictors of drug-eluting stent fractures in long coronary disease Hyun-Sook Kim a, Young-Hak Kim b,

More information

Evaluation of stent placement and outcomes with optical coherence tomography

Evaluation of stent placement and outcomes with optical coherence tomography REVIEW Evaluation of stent placement and outcomes with optical coherence tomography Optical coherence tomography (OCT) is an imaging modality based on fiberoptic technology. OCT imaging systems use optical

More information

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 2, NO. 5, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 2, NO. 5, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin JACC: CARDIOVASCULAR INTERVENTIONS VOL. 2, NO. 5, 2009 2009 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/09/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2009.01.012 Incomplete

More information

Bifurcation Stenting: IVUS and OCT Information

Bifurcation Stenting: IVUS and OCT Information Bifurcation Stenting: IVUS and OCT Information Yoshinobu Murasato MD, PhD (New Yukuhashi Hospital) On behalf of J-REVERSE investigators October 14-15, 2011, Lisbon Proximal stent deformation induced by

More information

Analysis of neointimal coverage after silolimus-eluting stent implantation using optical coherence tomography.

Analysis of neointimal coverage after silolimus-eluting stent implantation using optical coherence tomography. Analysis of neointimal coverage after silolimus-eluting stent implantation using optical coherence tomography. Division of Cardiology, Department of Internal Medicine, Fasculty of Medicine, Kinki University,

More information

Very late thrombosis of sirolimus-eluting stent due to late malapposition: Serial observations with optical coherence tomography

Very late thrombosis of sirolimus-eluting stent due to late malapposition: Serial observations with optical coherence tomography Journal of Cardiology (2008) 52, 290 295 CASE REPORT Very late thrombosis of sirolimus-eluting stent due to late malapposition: Serial observations with optical coherence tomography Takahiro Sawada (MD),

More information

Neointimal coverage of bare-metal and sirolimuseluting stents evaluated with optical coherence tomography

Neointimal coverage of bare-metal and sirolimuseluting stents evaluated with optical coherence tomography Neointimal coverage of bare-metal and sirolimuseluting stents evaluated with optical coherence tomography B X Chen, F Y Ma, W Luo, J H Ruan, W L Xie, X Z Zhao, S H Sun, X M Guo, F Wang, T Tian, X W Chu

More information

Drug Filled Stent Optical Coherence Tomography Results from RevElution Trial Stent Strut Coverage and Stent Apposition

Drug Filled Stent Optical Coherence Tomography Results from RevElution Trial Stent Strut Coverage and Stent Apposition Drug Filled Stent Optical Coherence Tomography Results from RevElution Trial Stent Strut Coverage and Stent Apposition Prof Martin Rothman on behalf of Dr. Stephen G. Worthley Alexandre Abizaid, Ajay J

More information

Differences in Clinical Outcomes Between Patients With ST-Elevation Versus Non-ST-Elevation Acute Myocardial Infarction in Korea

Differences in Clinical Outcomes Between Patients With ST-Elevation Versus Non-ST-Elevation Acute Myocardial Infarction in Korea REVIEW DOI 10.4070 / kcj.2009.39.8.297 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2009 The Korean Society of Cardiology Differences in Clinical Outcomes Between Patients With ST-Elevation

More information

Appearance of Lipid-Laden Intima and Neovascularization After Implantation of Bare-Metal Stents

Appearance of Lipid-Laden Intima and Neovascularization After Implantation of Bare-Metal Stents Journal of the American College of Cardiology Vol. 55, No. 1, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.08.032

More information

Optical coherence tomography patterns of in-stent restenosis: Comparison between bare-metal stent and drug-eluting stent

Optical coherence tomography patterns of in-stent restenosis: Comparison between bare-metal stent and drug-eluting stent Optical coherence tomography patterns of in-stent restenosis: Comparison between bare-metal stent and drug-eluting stent heart institute, Division of cardiology, Tokyo, Japan Yusuke Watanabe, Ryuta Asano,

More information

ORIGINAL ARTICLE. Methods. Imaging

ORIGINAL ARTICLE. Methods. Imaging Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp ORIGINAL ARTICLE Imaging Comparison of Neointimal Coverage of Sirolimus-Eluting Stents and Paclitaxel-Eluting

More information

Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Coronary Bifurcations

Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Coronary Bifurcations Journal of the American College of Cardiology Vol. 55, No. 16, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2010.02.008

More information

OCT; Comparative Imaging Results with IVUS, VH and Angioscopy

OCT; Comparative Imaging Results with IVUS, VH and Angioscopy OCT; Comparative Imaging Results with IVUS, VH and Angioscopy Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Comparison among coronary imaging techniques OCT IVUS MRI CAG Angioscopy

More information

REVIEWS. Causes, assessment, and treatment of stent thrombosis intravascular imaging insights. Daniel S. Ong and Ik-Kyung Jang

REVIEWS. Causes, assessment, and treatment of stent thrombosis intravascular imaging insights. Daniel S. Ong and Ik-Kyung Jang Causes, assessment, and treatment of stent thrombosis intravascular imaging insights Daniel S. Ong and Ik-Kyung Jang REVIEWS Abstract Stent thrombosis is a rare, but serious, complication of percutaneous

More information

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research The Cardiovascular

More information

PCI for In-Stent Restenosis. CardioVascular Research Foundation

PCI for In-Stent Restenosis. CardioVascular Research Foundation PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse

More information

Review Article Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement

Review Article Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement ombosis Volume 2012, Article ID 608593, 16 pages doi:10.1155/2012/608593 Review Article Pathologic Etiologies of Late and Very Late Stent ombosis following First-Generation Drug-Eluting Stent Placement

More information

OCT Technology: Differences between Biodegradable and Durable Polymers: Insights from the LEADERS Trial LEADERS OCT

OCT Technology: Differences between Biodegradable and Durable Polymers: Insights from the LEADERS Trial LEADERS OCT OCT Technology: Differences between Biodegradable and Durable Polymers: Insights from the LEADERS Trial LEADERS OCT Substudy Carlo Di Mario, MD Peter Barlis, MD Evelyn Regar, MD Peter Juni, MD Patrick

More information

Comparison of Coronary Artery Bypass Grafting With Drug-Eluting Stent Implantation for the Treatment of Multivessel Coronary Artery Disease

Comparison of Coronary Artery Bypass Grafting With Drug-Eluting Stent Implantation for the Treatment of Multivessel Coronary Artery Disease Comparison of Coronary Artery Bypass Grafting With Drug-Eluting Stent Implantation for the Treatment of Multivessel Coronary Artery Disease Jeong Hoon Yang, MD, Hyeon-Cheol Gwon, MD, Soo Jin Cho, MD, Joo

More information

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center 2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular

More information

Journal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30.

Journal of the American College of Cardiology Vol. 46, No. 5, by the American College of Cardiology Foundation ISSN /05/$30. Journal of the American College of Cardiology Vol. 46, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.06.009

More information

OCT Findings: Lesson from Stable vs Unstable Plaques

OCT Findings: Lesson from Stable vs Unstable Plaques ANGIOPLASTY SUMMIT TCTAP 2010 Imaging Workshop OCT Findings: Lesson from Stable vs Unstable Plaques Giulio Guagliumi MD Ospedali Riuniti di Bergamo, Italy DISCLOSURE OF FINANCIAL INTERESTS Consultant Boston

More information

Insights in Thrombosis and In-Stent Restenosis

Insights in Thrombosis and In-Stent Restenosis Clinical Value of OCT Insights in Thrombosis and In-Stent Restenosis Fernando Alfonso MD, PhD, FESC Interventional Cardiology. Cardiovascular Institute. Clinico San Carlos University Hospital. Madrid.

More information

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol

More information

OCT Analysis in Patients With Very Late Stent Thrombosis

OCT Analysis in Patients With Very Late Stent Thrombosis JACC: CARDIOVASCULAR IMAGING VOL. 6, NO. 6, 2013 ª 2013 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcmg.2013.02.006 OCT

More information

The wound healing response after implantation of a drug eluting stent is impaired persistently in the long term

The wound healing response after implantation of a drug eluting stent is impaired persistently in the long term DOI 10.1007/s00380-015-0676-y CASE REPORT The wound healing response after implantation of a drug eluting stent is impaired persistently in the long term Takahisa Nasuno 1 Michiaki Tokura 1 Michiya Kageyama

More information

Acta Cardiol Sin 2018;34: doi: /ACS _34(2) A

Acta Cardiol Sin 2018;34: doi: /ACS _34(2) A Original Article Acta Cardiol Sin 2018;34:124 129 doi: 10.6515/ACS.201803_34(2).20171115A Coronary Artery Disease Vascular Healing Response after Everolimus-Eluting Stent Implantation in Acute Coronary

More information

Successful Retrieval of Intravascular Stent Remnants With a Combination of Rotational Atherectomy and a Gooseneck Snare

Successful Retrieval of Intravascular Stent Remnants With a Combination of Rotational Atherectomy and a Gooseneck Snare Case Report Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Successful Retrieval of Intravascular Stent Remnants With a Combination of Rotational therectomy and a Gooseneck Snare

More information

Bioresorbable polymer drug-eluting stents in PCI

Bioresorbable polymer drug-eluting stents in PCI EARN 3 FREE CPD POINTS CARDIOVASCULAR Leader in digital CPD for Southern African healthcare professionals The BIOFLOW-V trial, using the Orsiro ultrathin strut stent with biodegradable polymer, showed

More information

The BIO revolution: bioadsorbable stents. Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino

The BIO revolution: bioadsorbable stents. Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino The BIO revolution: bioadsorbable stents Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino BVS stent (Abbot Vascular) Strut Material: Poly-L-Lactic acid Coating Material: Poly-D,L-lactide

More information

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. In-stent restenosis (ISR) Remains important issue even in the

More information

New Generation Drug- Eluting Stent in Korea

New Generation Drug- Eluting Stent in Korea New Generation Drug- Eluting Stent in Korea Young-Hak Kim, MD, PhD Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose To briefly introduce the

More information

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Left Anterior Descending Artery Ostial Stenosis PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary

More information

DES In-stent Restenosis

DES In-stent Restenosis DES In-stent Restenosis Roxana Mehran, MD Columbia University Medical Center The Cardiovascular Research Foundation DES Restenosis Mechanisms Predictors Morphological patterns Therapy approach Mechanisms

More information

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation ORIGINAL ARTICLE DOI 10.4070 / kcj.2010.40.1.10 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2010 The Korean Society of Cardiology Open Access The Effect of Cilostazol on Stent Thrombosis

More information

CYPHER (Polymer-based Sirolimus-eluting DES) New Stent Platforms. Campbell Rogers, M.D. Chief Technology Officer

CYPHER (Polymer-based Sirolimus-eluting DES) New Stent Platforms. Campbell Rogers, M.D. Chief Technology Officer Ground breaking, Life changing CYPHER (Polymer-based Sirolimus-eluting DES) New Stent Platforms Campbell Rogers, M.D. Chief Technology Officer Disclosure Statement of Financial Interest I am a full-time

More information

Stent Evaluation with Optical Coherence Tomography

Stent Evaluation with Optical Coherence Tomography Review Article http://dx.doi.org/10.3349/ymj.2013.54.5.1075 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 54(5):1075-1083, 2013 Stent Evaluation with Optical Coherence Tomography Seung-Yul Lee 1 and

More information

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

For Personal Use. Copyright HMP 2014

For Personal Use. Copyright HMP 2014 Original Contribution Thin-Strut Drug-Eluting Stents are More Favorable for Severe Calcified Lesions After Rotational Atherectomy Than Thick-Strut Drug-Eluting Stents Yasuharu Lee, MD, Akihiro Tanaka,

More information

A Randomized Optical Coherence Tomography Study of Coronary Stent Strut Coverage and Luminal Protrusion With Rapamycin-Eluting Stents

A Randomized Optical Coherence Tomography Study of Coronary Stent Strut Coverage and Luminal Protrusion With Rapamycin-Eluting Stents JACC: CARDIOVASCULAR INTERVENTIONS VOL. 2, NO. 5, 2009 2009 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/09/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2009.01.010 MINI-FOCUS:

More information

Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation

Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation Original Article Yonsei Med J Nov;():8- http://dx.doi.org/.9/ymj...8 pissn: -9 eissn: 9- Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation Sung-Jin

More information

Left main coronary artery (LMCA): The proximal segment

Left main coronary artery (LMCA): The proximal segment Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary

More information

DESolve NX Trial Clinical and Imaging Results

DESolve NX Trial Clinical and Imaging Results DESolve NX Trial Clinical and Imaging Results Alexandre Abizaid, MD, PhD, Instituto Dante Pazzanese, Sao Paulo, Brazil On behalf of the DESolve Nx Trial Investigators Please refer to the TCT2014 App or

More information

Vessel healings after stenting with different polymers in STEMI patients

Vessel healings after stenting with different polymers in STEMI patients Journal of Geriatric Cardiology (2016) 13: 306 311 2016 JGC All rights reserved; www.jgc301.com Research Article Open Access Vessel healings after stenting with different polymers in STEMI patients Qin-Hua

More information

INTRODUCTION. Catheterization and Cardiovascular Interventions 82:E871 E878 (2013)

INTRODUCTION. Catheterization and Cardiovascular Interventions 82:E871 E878 (2013) Catheterization and Cardiovascular Interventions 82:E871 E878 (2013) Two-Week Interval Optical Coherence Tomography: Imaging Evidence on Neointimal Coverage Completion After Implantation of the Endeavor

More information

IN-STENT RESTENOSIS. K.Boerlage-van Dijk CarVasZ 2014

IN-STENT RESTENOSIS. K.Boerlage-van Dijk CarVasZ 2014 IN-STENT RESTENOSIS K.Boerlage-van Dijk CarVasZ 2014 Definition ISR Angiographic: recurrent diameter stenosis >50% at the stent segment or edges (5-mm segments adjacent to stent) Mehran system morphological

More information

Sirolimus-Eluting Stents for Treatment of In-Stent Restenosis

Sirolimus-Eluting Stents for Treatment of In-Stent Restenosis Clinical Investigation Alfonso Medina, MD José Suárez de Lezo, MD Manuel Pan, MD Antonio Delgado, MD José Segura, MD Djordje Pavlovic, MD Francisco Melián, MD Miguel Romero, MD Federico Segura, MD Enrique

More information

Impact of Positive Peri-Stent Vascular Remodeling After Sirolimus-Eluting and Paclitaxel-Eluting Stent Implantation on 5-Year Clinical Outcomes

Impact of Positive Peri-Stent Vascular Remodeling After Sirolimus-Eluting and Paclitaxel-Eluting Stent Implantation on 5-Year Clinical Outcomes Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp ORIGINAL ARTICLE Cardiovascular Intervention Impact of Positive Peri-Stent Vascular Remodeling After Sirolimus-Eluting

More information

Optical Coherence Tomography for Intracoronary Imaging

Optical Coherence Tomography for Intracoronary Imaging Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland

More information

The Role of Optical Coherence Tomography in Coronary Intervention

The Role of Optical Coherence Tomography in Coronary Intervention review korean j intern med 2012;27:1-12 pissn 1226-3303 eissn 2005-6648 The Role of Optical Coherence Tomography in Coronary Intervention Mitsuyasu Terashima 1, Hideaki Kaneda 2, and Takahiko Suzuki 1

More information

Original Article. Introduction. Korean Circulation Journal

Original Article. Introduction. Korean Circulation Journal Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Impact of Heterogeneous Overlapping Drug-Eluting Stents on the Arterial Responses of Rabbit Iliac Arteries: A Comparison

More information

Review Article Comparison of 12-Month Outcomes with Zotarolimus- and Paclitaxel-Eluting Stents: A Meta-Analysis

Review Article Comparison of 12-Month Outcomes with Zotarolimus- and Paclitaxel-Eluting Stents: A Meta-Analysis International Scholarly Research Network ISRN Cardiology Volume 2011, Article ID 675638, 6 pages doi:10.5402/2011/675638 Review Article Comparison of 12-Month Outcomes with Zotarolimus- and Paclitaxel-Eluting

More information

Conflict of interest :None. Meta-analysis. Zhangwei Chen, MD

Conflict of interest :None. Meta-analysis. Zhangwei Chen, MD Meta-analysis Addition of Cilostazol to Conventional Dual Antiplatelet Therapy Reduces the Risk of Cardiac Events and Restenosis after Drug-Eluting Stent Implantation Zhangwei Chen, MD Department of Cardiology,

More information

Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents

Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents ORIGINAL ARTICLE Korean J Intern Med 2013;28:72-80 Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents Jang-Won

More information

Αγγειοπλαστική σε Eπαναστενωτικές Bλάβες

Αγγειοπλαστική σε Eπαναστενωτικές Bλάβες Αγγειοπλαστική σε Eπαναστενωτικές Bλάβες Βάιος Π. Τζίφος Δ/ντής Γ Καρδιολογικής Κλινικής - Επεμβατικής Καρδιολογίας. Ερρίκος Ντυνάν HC The Mehran s Classification for BMS-ISR Prognostic Value Pattern (1)

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Examination of the In Vivo Mechanisms of Late Drug-Eluting Stent Thrombosis

Examination of the In Vivo Mechanisms of Late Drug-Eluting Stent Thrombosis JACC: CARDIOVASCULAR INTERVENTIONS VOL. 5, NO. 1, 2012 2012 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.09.018 CLINICAL RESEARCH

More information

Stent Fracture and Longitudinal Compression on CT Angiography between the

Stent Fracture and Longitudinal Compression on CT Angiography between the 2014 ASCI Stent Fracture and Longitudinal Compression on CT Angiography between the First- and New-Generation Drug-Eluting Stent Mi Sun Chung, Dong Hyun Yang,Young-Hak Kim, Jae-Hyung Roh, Joon-Won Kang,

More information

BIOFREEDOM: Polymer free Biolimus A9 eluting

BIOFREEDOM: Polymer free Biolimus A9 eluting TCTAP 2011 Seoul, April 27 29, 2011 BIOFREEDOM: Polymer free Biolimus A9 eluting Stents and Paclitaxel eluting stents Eberhard Grube MD, FACC, FSCAI Hospital Oswaldo Cruz - Dante Pazzanese, São Paulo,

More information

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD

Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD Technical considerations in the Treatment of Left Main Lesions Ioannis Iakovou, MD, PhD Onassis Cardiac Surgery Center, Athens, Greece Critical issues in LM PCI Anatomic variability Techniques Variability

More information

Coronary Stent Choice in Patients With Diabetes Mellitus

Coronary Stent Choice in Patients With Diabetes Mellitus Rome Cardiology Forum 2014 Coronary Stent Choice in Patients With Diabetes Mellitus Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University

More information

Drug eluting stents From revolution to evolution. Current limitations

Drug eluting stents From revolution to evolution. Current limitations Drug eluting stents From revolution to evolution Current limitations Eric Eeckhout Centre Hospitalier Universitaire Vaudois Lausanne - Switzerland eric.eeckhout@chuv.ch Overview Historical perspective

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction

Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction Sungmin Lim, Yoon Seok Koh, Hee Yeol Kim, Ik Jun Choi, Eun Ho Choo, Jin Jin Kim, Mineok

More information

Optimal Duration of Clopidogrel Therapy with DES to Reduce Late Coronary Arterial Thrombotic Event. The DES LATE Trial

Optimal Duration of Clopidogrel Therapy with DES to Reduce Late Coronary Arterial Thrombotic Event. The DES LATE Trial Optimal Duration of Clopidogrel Therapy with DES to Reduce Late Coronary Arterial Thrombotic Event The DES LATE Trial Cheol Whan Lee, MD, Seung-Jung Park, MD, PhD, On Behalf of the DES LATE Investigators

More information

Second Generation Drug Eluting Stents: From Inhibition to Healing

Second Generation Drug Eluting Stents: From Inhibition to Healing Second Generation Drug Eluting Stents: From Inhibition to Healing Mitchell W. Krucoff MD, FACC Professor of Medicine / Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Duke

More information

Keywords: Drug-eluting balloon; Bare metal stent; Drug-eluting stents; Tomography, optical coherence; Ultrasonography, interventional

Keywords: Drug-eluting balloon; Bare metal stent; Drug-eluting stents; Tomography, optical coherence; Ultrasonography, interventional ORIGINAL ARTICLE 2018 Junl 4. [Epub ahead of print] Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions

More information

LCX. President / Director of Cardiology / New Tokyo Hospital

LCX. President / Director of Cardiology / New Tokyo Hospital LCX President / Director of Cardiology / New Tokyo Hospital Professor of Department of Advanced Cardiovascular Medicine: Kumamoto University Consultant / National Cardiovascular Center / Osaka Sunao Nakamura

More information

stent (stent fracture) clopidogrel in stent restenosis drug eluting stent(des) (overlap) mail:

stent (stent fracture) clopidogrel in stent restenosis drug eluting stent(des) (overlap) mail: stent (MD) (MD) clopidogrel (stent fracture) in stent restenosis drug eluting stent() stent post dilation, angulated) (overlap) mail: mehrdadsaravi@gmail.com J Babol Univ Med Sci; 11(5); Dec-Jan 2009-2010

More information

Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis Alaide Chieffo

Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis Alaide Chieffo Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis 11.45-12.07 Alaide Chieffo San Raffaele Scientific Institute, Milan, Italy Historical Perspective 25 20 15 10 5 0 Serruys 1991

More information

Side Branch Occlusion

Side Branch Occlusion Side Branch Occlusion Mechanism, Outcome, and How to avoid it From COBIS II Registry Hyeon-Cheol Gwon Cardiac&Vascular Center, Samsung Medical Center Sungkyunkwan University School of Medicine SB occlusion

More information

Inspiron Stent. Clinical Research Program. Pedro A. Lemos MD PhD. Heart Institute InCor University of Sao Paulo Medical School Sao Paulo Brazil

Inspiron Stent. Clinical Research Program. Pedro A. Lemos MD PhD. Heart Institute InCor University of Sao Paulo Medical School Sao Paulo Brazil Stent Clinical Research Program Pedro A. Lemos MD PhD Heart Institute InCor University of Sao Paulo Medical School Sao Paulo Brazil All faculty disclosures are available on the CRF Events App and online

More information

Research Article Pathological Perspective of Drug-Eluting Stent Thrombosis

Research Article Pathological Perspective of Drug-Eluting Stent Thrombosis Thrombosis Volume 2012, Article ID 219389, 8 pages doi:10.1155/2012/219389 Research Article Pathological Perspective of Drug-Eluting Stent Thrombosis Katsumi Inoue Department of Laboratory Medicine, Kokura

More information

Ενδοςτεφανιαίεσ προκζςεισ (stents):παρόν και μζλλον. Σ Χατηθμιλτιάδθσ Αναπλθρωτισ Κακθγθτισ Πανεπιςτθμιακό Νοςοκομείο ΑΧΕΠΑ

Ενδοςτεφανιαίεσ προκζςεισ (stents):παρόν και μζλλον. Σ Χατηθμιλτιάδθσ Αναπλθρωτισ Κακθγθτισ Πανεπιςτθμιακό Νοςοκομείο ΑΧΕΠΑ Ενδοςτεφανιαίεσ προκζςεισ (stents):παρόν και μζλλον Σ Χατηθμιλτιάδθσ Αναπλθρωτισ Κακθγθτισ Πανεπιςτθμιακό Νοςοκομείο ΑΧΕΠΑ DES Penetration -(2011) Source: Millenium Research Group Cordis has stopped manufacturing

More information

Accuracy of Optical Coherence Tomography in the Evaluation of Neointimal Coverage After Stent Implantation

Accuracy of Optical Coherence Tomography in the Evaluation of Neointimal Coverage After Stent Implantation JACC: CARDIOVASCULAR IMAGING VOL. 3, NO. 1, 21 21 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/1/$36. PUBLISHED BY ELSEVIER INC. DOI:1.116/j.jcmg.29.9.18 Accuracy of Optical Coherence

More information

Rationale for Percutaneous Revascularization ESC 2011

Rationale for Percutaneous Revascularization ESC 2011 Rationale for Percutaneous Revascularization Marie Claude Morice, Massy FR MD, FESC, FACC ESC 2011 Paris Villepinte - 27-31 August, 2011 Massy, France Potential conflicts of interest I have the following

More information

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Trends of acute myocardial infarction in Korea from the experience of Korea Acute

More information

PCI with Polymer-free Stent

PCI with Polymer-free Stent PCI with Polymer-free Stent Florian Krackhardt, M.D. Department of Cardiology Charité Campus Virchow-Klinikum University Hospital Berlin, Germany Drug Eluting Stents: Present Coating Technology Solution

More information

Cover Page. Author: Wang, Ancong Title: Automatic quantification of intravascular optical coherence tomography Issue Date:

Cover Page. Author: Wang, Ancong Title: Automatic quantification of intravascular optical coherence tomography Issue Date: Cover Page The handle http://hdl.handle.net/1887/29690 holds various files of this Leiden University dissertation Author: Wang, Ancong Title: Automatic quantification of intravascular optical coherence

More information

Acute and Subacute Stent Thrombosis in a Patient With Clopidogrel Resistance: A Case Report

Acute and Subacute Stent Thrombosis in a Patient With Clopidogrel Resistance: A Case Report CSE REPORT DOI 10.4070 / kcj.2009.39.10.434 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2009 The Korean Society of Cardiology Open ccess cute and Subacute Stent Thrombosis in a Patient With

More information

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of

More information